Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Product/R&D News
7/18/2025
China Approves Nation's First Recombinant Human Albumin Injection Deri...
7/17/2025
China Accepts Amgen and ONC Marketing Submission for Imdelltra in ES-S...
7/16/2025
AstraZeneca Secures First-Time Clinical Trial Approvals in China for F...
7/16/2025
Innovent Initiates Phase III Trial for IBI343 in Advanced Pancreatic C...
7/15/2025
China Clears IND for YolTech’s First-in-Class In Vivo Base Editing Th...
7/15/2025
Hengrui Prepares Chinese NDA for Kailera Drug After Phase 3 Obesity Wi...
7/14/2025
Shanghai Cell Therapy Unveils BZE2204: Rapid CAR‑T with Impressive Ef...
7/14/2025
Akeso Launches Phase II Study Combining BsAbs with Tinengotinib
7/14/2025
InnoCare Announces FDA Approval of Clinical Trial for BCL2 Inhibitor M...
7/14/2025
Ascentage's Lisaftoclax (APG‑2575) Gains NMPA Green Light for CLL/SLL
7/11/2025
Evopoint's CLDN18.2‑Targeting ADC XNW27011 Launches First Phase III T...
7/11/2025
Regenelead's KRAS-Targeted Cancer Vaccine Approved for Clinical Trials...
7/11/2025
BeOne's Tevimbra Wins EU Green Light for First-Line Nasopharyngeal Can...
7/10/2025
Henlius Wins Global Regulatory Clearance to Launch Phase 2 Trial of PD...
7/9/2025
Simcere Advances Rademikibart with NDA Submission for Atopic Dermatiti...
7/9/2025
Hansoh Pharma Launches Phase 1 Trial of HS-20093 with Adebrelimab in F...
7/8/2025
ArkBio's ADHD Drug Azstarys Granted Priority Review in China
7/8/2025
DualityBio Launches Phase 3 Trial of HER2 ADC DB‑1303 in China for Re...
7/8/2025
Hansoh Launches Phase 1 Combo Trial of HS‑20093 ADC in ES‑SCLC
7/8/2025
SCG Cell's IND for SCG101V Cleared in China
7/8/2025
CStone Launches Global Phase I/II Trial for Trispecific Antibody CS200...
7/4/2025
Legend Initiates First-in-Human Trial for LUCAR-G19 in Autoimmune Dise...
7/3/2025
AbbVie's Venclexta Approved in China for Second-Line Treatment of del1...
7/3/2025
Eli Lilly's Tirzepatide Approved in China for Treatment of Obstructive...
7/3/2025
Hengrui Medicine Gains NMPA Approval for Novel Dry Eye Treatment SHR80...
7/3/2025
CTTQ's Homegrown rFVIIa Wins NMPA Approval for Bleeding Disorders
7/3/2025
Belief BioMed Unveils 4-Year Follow-Up Data for Hemophilia B Gene Ther...
7/3/2025
Akeso Launches Clinical Trials for First Bispecific ADC
7/3/2025
Dizal's Lung Cancer Pill Gains FDA Nod, Challenging Rivals in EGFR Exo...
7/2/2025
HanchorBio and Henlius Ink Major Licensing Deal for I/O Candidate HCB1...
Page:
2
/
17
Total number of articles:
504
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit